查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451011

2024-2032 年再生醫學市場報告（按類型、應用、最終用戶和地區）

Regenerative Medicine Market Report by Type, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2023年全球再生醫學市場規模達222億美元。展望未來， IMARC Group預計到2032年市場規模將達到1,161億美元，2024-2032年複合年成長率（CAGR）為19.6%。日益成長的移植排斥問題、骨科疾病再生療法的需求不斷成長、牙齒再生不斷成長以及傷口癒合中藥物使用的不斷增加是推動市場發展的一些因素。

再生醫學代表了一個有前途的生物醫學科學領域，專注於恢復受損的組織和器官。它利用實驗室培養的幹細胞，安全地移植到體內，刺激骨骼、軟骨、血管和重要器官的再生。這種多維方法涵蓋細胞和非細胞再生療法，包括免疫調節和組織工程技術。除了組織修復之外，再生醫學在治療阿茲海默症、帕金森氏症、心血管疾病 (CVD)、骨質疏鬆症和脊髓損傷等慢性疾病方面也具有巨大潛力。隨著研究的進展，它為變革性治療帶來了希望，可以顯著改善患者的生活和醫療保健結果。

全球市場主要是由人口老化加劇所推動的。與此一致的是，糖尿病、心臟病和骨關節炎等慢性病盛行率的上升極大地促進了市場的成長。此外，幹細胞療法和基因工程的不斷發展的研究推動了再生醫學的創新。幹細胞和其他以細胞為基礎的療法在組織再生和修復方面的持續使用也正在催化市場。此外，再生醫學研究和開發的資金和監管支持正在為市場創造積極的前景。此外，生物技術的進步使得再生療法更加精確和有效，從而提振了市場。此外，患者對再生治療方案的認知不斷提高，也推動了市場的發展。

再生醫學市場趨勢/促進因素：

癌症治療產品需求不斷增加

癌症治療中不斷成長的產品需求正在刺激市場。癌症的特徵是不受控制的細胞生長，通常會導致組織損傷，這可以透過再生療法來解決。再生醫學可以開發標靶療法，修復由癌症或化療等治療副作用引起的受損組織。它的目的是最大限度地減少傳統癌症治療的令人衰弱的副作用，提高患者的整體生活品質。這些技術可以幫助調節腫瘤微環境，並有可能抑制癌症進展。它還透過修復治療期間受影響的免疫細胞或組織來補充新興的癌症免疫療法。穩健的研究和臨床試驗探索了再生療法在各種癌症類型中的潛力，促進了市場成長。再生療法徹底改變癌症治療的潛力吸引了研發投資。癌症盛行率的上升以及對更有效、對患者友好的治療方法的追求推動了癌症護理中對再生醫學的需求，極大地促進了市場的擴張。

免疫療法的快速進展

免疫療法的快速進步正在推動市場發展。免疫療法是再生醫學的一個子集，利用人體的免疫系統來對抗疾病，包括癌症和自體免疫疾病。 CAR-T 細胞療法和免疫檢查點抑制劑等免疫療法透過增強人體辨識和對抗癌細胞的能力，徹底改變了癌症治療。免疫療法的進步使得治療方法更加個人化，符合精準醫療的趨勢。與化療和放療等傳統治療方法相比，它們的嚴重副作用通常較少，從而改善了患者的治療效果。研究人員探索將免疫療法與再生方法結合，以提高治療效果，擴大再生醫學的範圍。穩健的臨床試驗和研究計畫專注於最佳化免疫療法，推動該領域的創新。目前正在研究免疫療法在癌症以外的應用，包括自體免疫疾病、傳染病和器官移植。免疫療法改變疾病管理的潛力吸引了大量的研發投資。提高患者對免疫療法的宣傳和認知有助於其採用和市場成長。

產品廣泛應用於整容手術和美容領域

產品在整容手術和美容領域的廣泛應用是該細分市場成長的驅動力。再生療法，包括脂肪幹細胞治療，用於乳房重建和臉部年輕化等手術中的自然組織增強。他們提供創新的抗衰老治療，例如富血小板血漿（PRP）療法和基於幹細胞的干涉措施，吸引了尋求年輕外表的個人。採用再生技術來最大程度地減少手術、事故或受傷造成的疤痕，進而提高美觀效果。基於幹細胞的再生療法用於頭髮修復，解決脫髮和禿頭問題。微創美容再生手術的興起吸引了尋求更短恢復時間和減少疤痕的患者。對再生美學的需求持續成長，吸引了該領域的投資和創新。再生美容手術的高患者滿意度和積極成果推動了口碑推薦和市場擴張。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球再生醫學市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 幹細胞治療
    • 市場走向
    • 市場預測
  • 生物材料
    • 市場走向
    • 市場預測
  • 組織工程
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：按應用

  • 骨移植替代品
    • 市場走向
    • 市場預測
  • 骨關節疾病
    • 市場走向
    • 市場預測
  • 皮膚科
    • 市場走向
    • 市場預測
  • 心血管
    • 市場走向
    • 市場預測
  • 中樞神經系統
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院
    • 市場走向
    • 市場預測
  • 專科診所
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allergan PLC (AbbVie Inc.)
    • Amgen Inc.
    • Baxter International Inc.
    • BD (Becton, Dickinson and Company)
    • Integra Lifesciences Holdings Corporation
    • Medtronic Plc
    • Mimedx Group Inc.
    • Novartis AG
    • Osiris Therapeutics Inc. (Smith & Nephew plc)
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A2517

The global regenerative medicine market size reached US$ 22.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 116.1 Billion by 2032, exhibiting a growth rate (CAGR) of 19.6% during 2024-2032. The increasing transplant rejection concerns, the rising demand for regenerative therapies for orthopedic conditions, the growing dental regeneration, and the escalating medicine use in wound healing are some of the factors propelling the market.

Regenerative medicine represents a promising biomedical science field focused on restoring damaged tissues and organs. It harnesses laboratory-cultivated stem cells, safely transplanted into the body to stimulate the regeneration of bones, cartilage, blood vessels, and vital organs. This multidimensional approach encompasses cellular and acellular regenerative therapies, including immunomodulation and tissue engineering techniques. Beyond tissue repair, regenerative medicine holds immense potential in treating chronic ailments like Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research advances, it offers hope for transformative treatments that could significantly improve patients' lives and healthcare outcomes.

The global market is majorly driven by the increasing aging population. In line with this, the rising prevalence of chronic diseases such as diabetes, heart disease, and osteoarthritis is significantly contributing to the market growth. Furthermore, the growing research in stem cell therapies and genetic engineering drives innovation in regenerative medicine. The escalating use of stem cells and other cell-based therapies for tissue regeneration and repair is also catalyzing the market. Moreover, the funding and regulatory support for regenerative medicine research and development are creating a positive outlook for the market. Besides, the advancements in biotechnology enable more precise and effective regenerative therapies, bolstering the market. Additionally, the increasing awareness among patients about regenerative treatment options is providing a boost to the market.

Regenerative Medicine Market Trends/Drivers:

Increasing product demand in cancer treatment

The increasing product demand in cancer treatment is catalyzing the market. Cancer, characterized by uncontrolled cell growth, often leads to tissue damage, which can be addressed through regenerative therapies. Regenerative medicine allows for the development of targeted therapies that can repair damaged tissues caused by cancer or side effects of treatments like chemotherapy. It aims to minimize traditional cancer treatment's debilitating side effects, enhancing patients' overall quality of life. These techniques can help modulate the tumor microenvironment, potentially inhibiting cancer progression. It also complements emerging cancer immunotherapies by repairing immune cells or tissues affected during treatment. Robust research and clinical trials explore the potential of regenerative therapies in various cancer types, fostering market growth. The potential for regenerative therapies to revolutionize cancer treatment attracts investment in research and development. The rising prevalence of cancer and the pursuit of more effective, patient-friendly treatments fuel the demand for regenerative medicine in cancer care, contributing significantly to the market's expansion.

Rapid advancements in immunotherapy

Rapid advancements in immunotherapy are propelling the market. Immunotherapy, a subset of regenerative medicine, harnesses the body's immune system to fight diseases, including cancer and autoimmune disorders. Immunotherapies like CAR-T cell therapy and immune checkpoint inhibitors have revolutionized cancer treatment by enhancing the body's ability to recognize and combat cancer cells. Advances in immunotherapy enable more personalized treatment approaches, aligning with the trend toward precision medicine. They often have fewer severe side effects than traditional treatments like chemotherapy and radiation therapy, improving patient outcomes. Researchers explore combining immunotherapies with regenerative approaches to enhance treatment efficacy, expanding the scope of regenerative medicine. Robust clinical trials and research initiatives focus on optimizing immunotherapies, driving innovation in the field. Immunotherapies are being investigated for applications beyond cancer, including autoimmune diseases, infectious diseases, and organ transplantation. The potential of immunotherapy to transform disease management attracts substantial investments in research and development. Increasing patient advocacy and awareness of immunotherapies contribute to their adoption and market growth.

Widespread product applications in cosmetic surgery and aesthetics

The widespread product applications in cosmetic surgery and aesthetics are a driving force behind the growth of this market segment. Regenerative therapies, including adipose-derived stem cell treatments, are used for natural tissue augmentation in procedures like breast reconstruction and facial rejuvenation. They offer innovative anti-aging treatments, such as platelet-rich plasma (PRP) therapy and stem cell-based interventions, appealing to individuals seeking youthful appearances. Regenerative techniques are employed to minimize the appearance of scars resulting from surgeries, accidents, or injuries, enhancing aesthetic outcomes. Stem cell-based regenerative therapies are utilized for hair restoration, addressing hair loss and baldness concerns. The rise of minimally invasive aesthetic regenerative procedures appeals to patients seeking shorter recovery times and reduced scarring. The demand for regenerative aesthetics continues to grow, attracting investments and innovations in the field. High patient satisfaction rates and positive outcomes in regenerative aesthetic procedures drive word-of-mouth referrals and market expansion.

Regenerative Medicine Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global regenerative medicine market report, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on type, application, and end user.

Breakup by Type:

Stem Cell Therapy

Biomaterial

Tissue Engineering

Others

Stem cell therapy dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes stem cell therapy, biomaterial, tissue engineering, and others. According to the report, stem cell therapy represented the largest segment.

Stem cell therapy harnesses the unique regenerative properties of stem cells to repair and replace damaged or dysfunctional tissues and organs. It offers diverse therapeutic applications, including orthopedics, cardiology, neurology, and oncology. This versatility attracts investment and research, expanding its market presence. Clinical trials and case studies demonstrate the effectiveness of stem cell therapies in treating previously incurable conditions, boosting patient and physician confidence. With the global population aging, there's an increasing prevalence of age-related diseases and degenerative conditions, driving demand for regenerative treatments.

Furthermore, the regulatory bodies recognize stem cell therapies' potential, resulting in streamlined approvals and guidelines, further encouraging market growth. Patients seeking alternatives to conventional treatments are turning to stem cell therapies for better outcomes and reduced side effects. The potential of stem cell therapies attracts investments, fostering research and development and expanding accessibility. Advances in stem cell isolation, culturing, and delivery methods improve treatment efficacy, expanding their applications. Stem cell therapy providers are expanding their reach globally, making these treatments available to a wider patient population.

Breakup by Application:

Bone Graft Substitutes

Osteoarticular Diseases

Dermatology

Cardiovascular

Central Nervous System

Others

Dermatology dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes bone graft substitutes, osteoarticular diseases, dermatology, cardiovascular, central nervous system, and others. According to the report, dermatology represented the largest segment.

Dermatology is a vital application within regenerative medicine, focusing on the restoration and regeneration of skin tissues. It addresses a wide spectrum of dermatological concerns, ranging from scar reduction and wound healing to treating skin disorders and aging-related skin conditions.

Regenerative approaches in dermatology include using stem cells, growth factors, and tissue engineering techniques, offering patients innovative and minimally invasive solutions for achieving healthier, more youthful, and blemish-free skin. This segment is gaining traction due to the growing demand for cosmetic and aesthetic enhancements and the need for effective treatments for various skin ailments, ultimately contributing to the overall growth of the regenerative medicine market.

Breakup by End User:

Hospitals

Specialty Clinics

Others

Hospitals dominate the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, specialty clinics, and others. According to the report, hospitals represented the largest segment.

Hospitals serve as prominent end users within the regenerative medicine market, playing a pivotal role in the adoption and growth of regenerative therapies. They serve as hubs for advanced medical care and are integral for several reasons. Hospitals provide the infrastructure and expertise necessary for conducting complex regenerative procedures, such as organ transplants and stem cell therapies, ensuring patient safety and optimal outcomes. They also facilitate clinical trials and research initiatives, allowing for the development and testing innovative regenerative treatments.

Furthermore, hospitals are key in delivering regenerative therapies to patients, especially acute injuries, chronic diseases, or conditions requiring specialized medical attention. As healthcare institutions embrace regenerative medicine, hospitals remain central in its expansion, offering hope and cutting-edge treatments to a diverse patient population.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America represents a significant region in the regenerative medicine market, driving growth through several key factors. The region's advanced healthcare infrastructure, robust research and development capabilities, and high healthcare expenditure contribute to the adoption of regenerative therapies. It is home to numerous renowned research institutions, biotechnology companies, and academic centers specializing in regenerative medicine, fostering innovation and clinical advancements.

Regulatory support and well-defined approval processes in countries like the United States accelerate the introduction of regenerative treatments to the market. A growing aging population with age-related conditions also fuels the demand for regenerative solutions. Moreover, a strong focus on addressing chronic diseases, sports injuries, and aesthetic concerns further propels the use of regenerative therapies in North America. These factors collectively position North America as a prominent growth driver in the regenerative medicine sector.

Competitive Landscape:

Top companies are strengthening the market through innovation, strategic partnerships, and extensive research. They invest heavily in research and development, pushing the boundaries of regenerative medicine, uncovering new therapies, and expanding treatment options. They conduct large-scale clinical trials to demonstrate the safety and efficacy of regenerative therapies, gaining regulatory approvals and boosting market confidence. Top companies develop a diverse portfolio of regenerative products, catering to various medical conditions and applications, from orthopedics to oncology. These companies expand globally, ensuring wider access to their therapies and increasing market reach. Partnerships with research institutions, healthcare providers, and pharmaceutical companies facilitate knowledge sharing and the development of novel therapies. They navigate complex regulatory landscapes, ensuring their therapies meet stringent safety and quality standards instilling trust in healthcare professionals and patients. Top companies engage in patient advocacy and education, raising awareness about the benefits of regenerative medicine, thus driving demand. Their track record of success attracts investments, enabling further research and development of groundbreaking therapies.

The report has provided a comprehensive analysis of the competitive landscape in the regenerative medicine market. Detailed profiles of all major companies have also been provided.

Allergan PLC (AbbVie Inc.)

Amgen Inc.

Baxter International Inc.

BD (Becton, Dickinson and Company)

Integra Lifesciences Holdings Corporation

Medtronic plc

Mimedx Group Inc.

Novartis AG

Osiris Therapeutics Inc. (Smith & Nephew plc)

Thermo Fisher Scientific Inc

Recent Developments:

In May 2020, AbbVie acquired Allergan, expanding its aesthetics and regenerative medicine portfolio.

In 2021, Amgen initiated clinical trials for regenerative medicine candidates, focusing on stem cell therapies for neurological and cardiovascular conditions.

In 2020, Integra Lifesciences expanded its regenerative product portfolio by launching new wound care solutions.

Key Questions Answered in This Report:

  • How has the global regenerative medicine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global regenerative medicine market?
  • What is the impact of each driver, restraint, and opportunity on the global regenerative medicine market?
  • What are the key regional markets?
  • Which countries represent the most attractive regenerative medicine market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the regenerative medicine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the regenerative medicine market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the regenerative medicine market?
  • What is the competitive structure of the global regenerative medicine market?
  • Who are the key players/companies in the global regenerative medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Regenerative Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Biomaterial
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Tissue Engineering
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Dermatology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Central Nervous System
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Specialty Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allergan PLC (AbbVie Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Baxter International Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BD (Becton, Dickinson and Company)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Integra Lifesciences Holdings Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Medtronic Plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Mimedx Group Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Novartis AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Osiris Therapeutics Inc. (Smith & Nephew plc)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Regenerative Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Regenerative Medicine Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Regenerative Medicine Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Regenerative Medicine Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Regenerative Medicine Market: Breakup by End User (in %), 2023
  • Figure 6: Global: Regenerative Medicine Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Regenerative Medicine Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 8: Global: Regenerative Medicine (Stem Cell Therapy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Regenerative Medicine (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Regenerative Medicine (Biomaterial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Regenerative Medicine (Biomaterial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Regenerative Medicine (Tissue Engineering) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Regenerative Medicine (Tissue Engineering) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Regenerative Medicine (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Regenerative Medicine (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Regenerative Medicine (Bone Graft Substitutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Regenerative Medicine (Bone Graft Substitutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Regenerative Medicine (Osteoarticular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Regenerative Medicine (Osteoarticular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Regenerative Medicine (Dermatology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Regenerative Medicine (Dermatology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Regenerative Medicine (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Regenerative Medicine (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Regenerative Medicine (Central Nervous System) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Regenerative Medicine (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Regenerative Medicine (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Regenerative Medicine (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Regenerative Medicine (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Regenerative Medicine (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Regenerative Medicine (Specialty Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Regenerative Medicine (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Regenerative Medicine (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Regenerative Medicine (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: North America: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: North America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: United States: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: United States: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Canada: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Canada: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Asia Pacific: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Asia Pacific: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: China: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: China: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Japan: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Japan: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: India: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: India: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: South Korea: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: South Korea: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Australia: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Australia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Indonesia: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Indonesia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Europe: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Europe: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Germany: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Germany: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: France: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: France: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: United Kingdom: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: United Kingdom: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Italy: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Italy: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Spain: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Spain: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Russia: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Russia: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Latin America: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Latin America: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Brazil: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Brazil: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Mexico: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Mexico: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Others: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Others: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Middle East and Africa: Regenerative Medicine Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Middle East and Africa: Regenerative Medicine Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Regenerative Medicine Industry: SWOT Analysis
  • Figure 83: Global: Regenerative Medicine Industry: Value Chain Analysis
  • Figure 84: Global: Regenerative Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Regenerative Medicine Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Regenerative Medicine Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Regenerative Medicine Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Regenerative Medicine Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Regenerative Medicine Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Regenerative Medicine Market Structure
  • Table 7: Global: Regenerative Medicine Market: Key Players